Currently holds positions in Stemline Therapeutics Inc and Beyond Air Inc
Position | Company | Period |
---|---|---|
Independent Director | Stemline Therapeutics Inc | Jan. 1, 2009 - |
Independent Director | Beyond Air Inc | Jan. 13, 2017 - |
Chief Executive Officer, Director | Urogen Pharma Ltd | Oct. 1, 2015 - Jan. 3, 2019 |
Executive Chairman of the Board | Beyond Air Inc | Aug. 1, 2015 - Jan. 13, 2017 |
Chief Executive Officer, Director | Keryx Biopharmaceuticals Inc | June 16, 2009 - April 30, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-19 | 2024-03-18 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
5,000
+0.2%
10.2951,450 USD |
5,000 +0.2% | 10.29 | 51,450 USD | |
2023-10-12 | 2023-10-10 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
640
+0.0%
11.087,091 USD |
640 +0.0% | 11.08 | 7,091 USD | |
2023-10-10 | 2023-10-09 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
830
+0.0%
11.199,288 USD |
830 +0.0% | 11.19 | 9,288 USD | |
2023-10-10 | 2023-10-06 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
250
+0.0%
11.272,818 USD |
250 +0.0% | 11.27 | 2,818 USD | |
2023-08-11 | 2023-08-11 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
180
+0.0%
14.662,639 USD |
180 +0.0% | 14.66 | 2,639 USD | |
2023-08-11 | 2023-08-08 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
120
+0.0%
14.831,780 USD |
120 +0.0% | 14.83 | 1,780 USD | |
2023-07-24 | 2023-07-21 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
225
+0.0%
14.853,341 USD |
225 +0.0% | 14.85 | 3,341 USD | |
2023-07-24 | 2023-07-20 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
110
+0.0%
15.061,657 USD |
110 +0.0% | 15.06 | 1,657 USD | |
2023-07-20 | 2023-07-19 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
200
+0.0%
14.332,866 USD |
200 +0.0% | 14.33 | 2,866 USD | |
2023-07-18 | 2023-07-14 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
150
+0.0%
15.032,255 USD |
150 +0.0% | 15.03 | 2,255 USD | |
2023-07-18 | 2023-07-07 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
110
+0.0%
16.191,781 USD |
110 +0.0% | 16.19 | 1,781 USD | |
2023-07-07 | 2023-07-06 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
320
+0.0%
14.884,762 USD |
320 +0.0% | 14.88 | 4,762 USD | |
2023-06-27 | 2023-06-26 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
750
+0.0%
16.5012,375 USD |
750 +0.0% | 16.50 | 12,375 USD | |
2023-06-22 | 2023-06-21 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
17.888,940 USD |
500 +0.0% | 17.88 | 8,940 USD | |
2023-06-08 | 2023-06-08 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
120
+0.0%
17.532,104 USD |
120 +0.0% | 17.53 | 2,104 USD | |
2023-06-08 | 2023-06-07 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
230
+0.0%
17.414,004 USD |
230 +0.0% | 17.41 | 4,004 USD | |
2023-06-01 | 2023-05-31 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
330
+0.0%
17.285,702 USD |
330 +0.0% | 17.28 | 5,702 USD | |
2023-05-26 | 2023-05-24 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
200
+0.0%
17.493,498 USD |
200 +0.0% | 17.49 | 3,498 USD | |
2023-05-18 | 2023-05-16 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
320
+0.0%
17.035,448 USD |
320 +0.0% | 17.03 | 5,448 USD | |
2023-03-27 | 2023-03-23 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
230
+0.0%
12.132,790 USD |
230 +0.0% | 12.13 | 2,790 USD | |
2023-03-23 | 2023-03-21 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
480
+0.0%
12.085,798 USD |
480 +0.0% | 12.08 | 5,798 USD | |
2023-03-21 | 2023-03-20 |
Beyond Air Inc
(XAIR)
|
B Purchase |
2,300
+1.6%
6.4814,904 USD |
2,300 +1.6% | 6.48 | 14,904 USD | |
2023-03-16 | 2023-03-15 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
480
+0.0%
10.915,237 USD |
480 +0.0% | 10.91 | 5,237 USD | |
2023-03-16 | 2023-03-14 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,680
+0.1%
10.8518,228 USD |
1,680 +0.1% | 10.85 | 18,228 USD | |
2022-11-30 | 2022-11-30 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
150
+0.0%
7.451,118 USD |
150 +0.0% | 7.45 | 1,118 USD | |
2022-11-29 | 2022-11-29 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
150
+0.0%
7.451,118 USD |
150 +0.0% | 7.45 | 1,118 USD | |
2022-11-29 | 2022-11-28 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
150
+0.0%
7.401,110 USD |
150 +0.0% | 7.40 | 1,110 USD | |
2022-11-29 | 2022-11-25 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
150
+0.0%
7.381,107 USD |
150 +0.0% | 7.38 | 1,107 USD | |
2022-11-21 | 2022-11-18 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
7.233,615 USD |
500 +0.0% | 7.23 | 3,615 USD | |
2022-11-21 | 2022-11-17 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
250
+0.0%
7.241,810 USD |
250 +0.0% | 7.24 | 1,810 USD | |
2022-11-16 | 2022-11-10 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,000
+0.0%
7.077,070 USD |
1,000 +0.0% | 7.07 | 7,070 USD | |
2022-10-03 | 2022-09-30 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
7.463,730 USD |
500 +0.0% | 7.46 | 3,730 USD | |
2022-10-03 | 2022-09-28 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
7.233,615 USD |
500 +0.0% | 7.23 | 3,615 USD | |
2022-09-27 | 2022-09-26 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
7.693,845 USD |
500 +0.0% | 7.69 | 3,845 USD | |
2022-09-27 | 2022-09-23 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,000
+0.0%
7.937,930 USD |
1,000 +0.0% | 7.93 | 7,930 USD | |
2022-09-06 | 2022-09-02 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,200
+0.0%
8.3710,044 USD |
1,200 +0.0% | 8.37 | 10,044 USD | |
2022-09-06 | 2022-09-01 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
8.114,055 USD |
500 +0.0% | 8.11 | 4,055 USD | |
2022-08-30 | 2022-08-29 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,000
+0.0%
9.079,070 USD |
1,000 +0.0% | 9.07 | 9,070 USD | |
2022-08-22 | 2022-08-19 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
5,000
+0.2%
8.9944,950 USD |
5,000 +0.2% | 8.99 | 44,950 USD | |
2022-08-22 | 2022-08-18 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
14,426
+0.5%
8.58123,775 USD |
14,426 +0.5% | 8.58 | 123,775 USD | |
2022-08-16 | 2022-08-11 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
19,669
+0.7%
8.40165,220 USD |
19,669 +0.7% | 8.40 | 165,220 USD | |
2022-07-05 | 2022-06-30 |
Beyond Air Inc
(XAIR)
|
S Sale |
40,000
-21.9%
6.53261,104 USD |
40,000 -21.9% | 6.53 | 261,104 USD | |
2022-06-27 | 2022-06-24 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
400
+0.0%
12.184,872 USD |
400 +0.0% | 12.18 | 4,872 USD | |
2022-06-27 | 2022-06-23 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
200
+0.0%
11.402,280 USD |
200 +0.0% | 11.40 | 2,280 USD | |
2022-06-27 | 2022-06-22 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
100
+0.0%
13.101,310 USD |
100 +0.0% | 13.10 | 1,310 USD | |
2022-05-31 | 2022-05-27 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
15.747,870 USD |
500 +0.0% | 15.74 | 7,870 USD | |
2022-05-31 | 2022-05-26 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
500
+0.0%
15.907,950 USD |
500 +0.0% | 15.90 | 7,950 USD | |
2022-05-23 | 2022-05-20 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,000
+0.0%
16.2816,280 USD |
1,000 +0.0% | 16.28 | 16,280 USD | |
2022-05-23 | 2022-05-19 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
200
+0.0%
18.953,790 USD |
200 +0.0% | 18.95 | 3,790 USD | |
2022-05-19 | 2022-05-18 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,000
+0.0%
18.4918,490 USD |
1,000 +0.0% | 18.49 | 18,490 USD | |
2022-05-19 | 2022-05-18 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
700
+0.0%
20.6014,420 USD |
700 +0.0% | 20.60 | 14,420 USD | |
2022-05-19 | 2022-05-17 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
110
+0.0%
20.832,291 USD |
110 +0.0% | 20.83 | 2,291 USD | |
2022-05-19 | 2022-05-17 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
200
+0.0%
19.773,954 USD |
200 +0.0% | 19.77 | 3,954 USD | |
2022-05-17 | 2022-05-16 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,000
+0.0%
19.3219,320 USD |
1,000 +0.0% | 19.32 | 19,320 USD | |
2022-05-17 | 2022-05-13 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
700
+0.0%
18.1012,670 USD |
700 +0.0% | 18.10 | 12,670 USD | |
2022-05-13 | 2022-05-12 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
10,545
+0.4%
17.26182,007 USD |
10,545 +0.4% | 17.26 | 182,007 USD | |
2022-05-13 | 2022-05-12 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
600
+0.0%
16.129,672 USD |
600 +0.0% | 16.12 | 9,672 USD | |
2022-05-13 | 2022-05-12 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
1,100
+0.0%
14.8816,368 USD |
1,100 +0.0% | 14.88 | 16,368 USD | |
2022-03-29 | 2022-03-28 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
4,000
+0.1%
7.0528,200 USD |
4,000 +0.1% | 7.05 | 28,200 USD | |
2022-03-18 | 2022-03-17 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
7,000
+0.2%
7.6353,410 USD |
7,000 +0.2% | 7.63 | 53,410 USD | |
2022-02-15 | 2022-02-14 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
8,000
+0.3%
5.8847,040 USD |
8,000 +0.3% | 5.88 | 47,040 USD | |
2022-02-11 | 2022-02-10 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
8,500
+0.3%
6.3453,890 USD |
8,500 +0.3% | 6.34 | 53,890 USD | |
2022-02-08 | 2022-02-07 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
6,000
+0.2%
8.2549,500 USD |
6,000 +0.2% | 8.25 | 49,500 USD | |
2022-02-08 | 2022-02-07 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
14,000
+0.5%
3.9355,020 USD |
14,000 +0.5% | 3.93 | 55,020 USD | |
2022-02-08 | 2022-02-04 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
12,500
+0.5%
3.8948,625 USD |
12,500 +0.5% | 3.89 | 48,625 USD | |
2022-02-08 | 2022-02-04 |
Nuvectis Pharma Inc
(NVCT)
|
B Purchase |
200,000
+7.8%
5.001,000,000 USD |
200,000 +7.8% | 5.00 | 1,000,000 USD | |
2021-11-26 | 2021-11-24 |
Beyond Air Inc
(XAIR)
|
S Sale |
6,464
-3.4%
13.9990,431 USD |
6,464 -3.4% | 13.99 | 90,431 USD | |
2021-11-26 | 2021-11-24 |
Beyond Air Inc
(XAIR)
|
S Sale |
31,000
-14.1%
13.44416,640 USD |
31,000 -14.1% | 13.44 | 416,640 USD | |
2021-02-18 | 2021-02-12 |
Beyond Air Inc
(XAIR)
|
S Sale |
23,419
-11.4%
6.36148,945 USD |
23,419 -11.4% | 6.36 | 148,945 USD | |
2021-02-18 | 2021-02-11 |
Beyond Air Inc
(XAIR)
|
S Sale |
1,500
-0.8%
6.289,420 USD |
1,500 -0.8% | 6.28 | 9,420 USD | |
2021-02-08 | 2021-01-02 |
Beyond Air Inc
(XAIR)
|
S Sale |
5,700
-3.0%
5.8933,573 USD |
5,700 -3.0% | 5.89 | 33,573 USD | |
2020-08-27 | 2020-08-25 |
Beyond Air Inc
(XAIR)
|
PS Planned sale |
1,580
-0.8%
5.959,406 USD |
1,580 -0.8% | 5.95 | 9,406 USD | |
2020-08-25 | 2020-08-24 |
Beyond Air Inc
(XAIR)
|
PS Planned sale |
3,889
-2.0%
5.6822,104 USD |
3,889 -2.0% | 5.68 | 22,104 USD | |
2020-08-25 | 2020-08-21 |
Beyond Air Inc
(XAIR)
|
PS Planned sale |
3,246
-1.6%
6.0519,651 USD |
3,246 -1.6% | 6.05 | 19,651 USD | |
2020-08-21 | 2020-08-20 |
Beyond Air Inc
(XAIR)
|
PS Planned sale |
3,778
-1.9%
6.2923,780 USD |
3,778 -1.9% | 6.29 | 23,780 USD |